Skip to main content
. 2020 Aug 26;50(5):1454–1460. doi: 10.3906/sag-2001-268

Figure 3.

Figure 3

a: HA applied tibia, two weeks treatment, stained with MT, ×25 magnification; b: HA applied tibia, two weeks treatment, stained with HE, ×25 magnification; c: NPY dose1 applied tibia, two weeks treatment, stained with HE, ×50 magnification; d: NPY1 receptor antagonist applied tibia, two weeks treatment, stained with Masson trichrome technique, ×25 magnification. The arrow shows the green stained new bone formation.